These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19008804)

  • 1. [Cerebrolysin alleviates perinatal CNS disorders through the autoimmune modulation and antioxidant protection].
    Serkina EV; Gromova OA; Torshin IIu; Sotnikova NIu; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):62-6. PubMed ID: 19008804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats--protective effects of Cerebrolysin.
    Schwab M; Schaller R; Bauer R; Zwiener U
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):29-37. PubMed ID: 9085071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of cerebrolysin on the clinical symptoms and the course of ischemic encephalopathy].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):42-5. PubMed ID: 15704482
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiological effects and brain protection by hypothermia and cerebrolysin after moderate forebrain ischemia in rats.
    Schwab M; Bauer R; Zwiener U
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):105-16. PubMed ID: 9085084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of cerebrolysin in the treatment of ischemic stroke].
    Koppi S; Barolin GS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):30-3. PubMed ID: 9819885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The experience with endolumbar application of cerebrolysin in hemispheric ischemic stroke].
    Vilenskiĭ BS; Odinak MM; Shirokov EA; Vozniuk IA; Semenova GM; Grinevich TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(11):31-4. PubMed ID: 11247183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin.
    Onose G; Mureşanu DF; Ciurea AV; Daia Chendreanu C; Mihaescu AS; Mardare DC; Andone I; Spânu A; Popescu C; Dumitrescu A; Popescu M; Grigorean V; Ungur B; Marinescu F; Colibbeanu I; Onose L; Haras M; Sandu A; Spircu T
    J Med Life; 2009; 2(4):350-60. PubMed ID: 20108748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin and its emerging clinical applications in psychiatry.
    Kapoor S
    Aust N Z J Psychiatry; 2013 Jul; 47(7):685. PubMed ID: 23405015
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction].
    Konoplya AI; Laskov VB; Shul'ginova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):28-32. PubMed ID: 26978048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
    Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
    Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
    Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of efficiency of ceraxon in the treatment of lag psychomotor development of children with hypoxic-ischemic lesions of central nervous system].
    Rubtsova IeI; Klimova TM; Hechko KhA
    Wiad Lek; 2014; 67(2 Pt 2):248-50. PubMed ID: 25796838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological evaluation of long-term therapy of Alzheimer's disease using different cerebrolysin dosages].
    Roshchina IF; Gavrilova SI; Zharikov GA; Kalyn IaB; Kolykhalov IV; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):52-5. PubMed ID: 15704485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of cerebrolysin intravenous injections in resistant forms of night enuresis in children].
    Gruzman AV; Levina IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(11):46. PubMed ID: 9845942
    [No Abstract]   [Full Text] [Related]  

  • 15. Can Cerebrolysin influence chronic deterioration of spatial learning and memory?
    Valousková V; Francis-Turner L
    J Neural Transm Suppl; 1998; 53():343-9. PubMed ID: 9700670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with Cerebrolysin.
    Molloy DW; Standish TI
    J Neural Transm Suppl; 2000; 59():293-300. PubMed ID: 10961441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of different salt diets and the modulation of the protective action of cerebrolysin in an experimental disturbance of the cerebral circulation].
    Shtrygol' OIu; Sadin AV; Konkina EA; Branchevskiĭ LL
    Eksp Klin Farmakol; 2000; 63(1):29-32. PubMed ID: 10763106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke.
    Niu FN; Zhang X; Hu XM; Chen J; Chang LL; Li JW; Liu Z; Cao W; Xu Y
    Brain Behav Immun; 2012 Jan; 26(1):61-71. PubMed ID: 21802508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
    Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
    Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
    Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
    Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.